Anjanetta Foster
Internal Medicine · Birmingham, ALNPI 1528164522
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 441 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by Novo Nordisk at 24.1% of the total. Reporting peaked in 2019 at $2,554 and has fallen 62.0% since, to $970 in 2022. Among internal medicine clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 441 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$964
- Boehringer Ingelheim$603
- Astellas Pharma US Inc$506
- Pfizer$403
- Lilly USA, LLC$367
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,90898%
- Education$1062%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 111 | $1,692 |
| AstraZeneca | 59 | $964 |
| Boehringer Ingelheim | 42 | $603 |
| Astellas Pharma US Inc | 29 | $506 |
| Pfizer | 29 | $403 |
| Lilly USA, LLC | 25 | $367 |
| Sanofi-aventis U.S. LLC | 14 | $335 |
| AbbVie(2 entities) | 18 | $230 |
| Merck | 15 | $223 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $215 |
| GSK | 13 | $194 |
| Ironwood Pharmaceuticals, Inc | 12 | $174 |
| Johnson & Johnson | 9 | $168 |
| Abbott | 6 | $149 |
| Novartis | 6 | $112 |
| Sunovion Pharmaceuticals Inc. | 9 | $103 |
| Pacira Therapeutics, Inc. | 1 | $90 |
| Amgen | 4 | $75 |
| Esperion Therapeutics, Inc. | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 4 | $61 |
| Intra-sana Laboratories | 1 | $32 |
| Irhythm Technologies, Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| MDD US Operations, LLC | 2 | $25 |
| Alkermes, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| UCB, Inc. | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,014 in reported general payments places this provider in the 90th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Birmingham
- Ryan WeldonBirmingham$458K
- Robert LewisBirmingham$187K
- Thomas HuddleBirmingham$76K
- Jose VargasBirmingham$49K
- Donna FicoBirmingham$46K
- James SullivanBirmingham$39K
- Ross SchumacherBirmingham$26K
- Larry AlfordBirmingham$25K
- David WynneBirmingham$22K
- James CrenshawBirmingham$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.